8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2003 / Intervention feeding study and in vitro experiment
Participants were fed a meal containing 400 mg cholestan-5alpha,6alpha-epoxy-3beta-ol (alpha-epoxy cholesterol). In serum, alpha-epoxy cholesterol appeared in chylomicron/chylomicron remnants (CM/RM) and endogenous lipoproteins (VLDL, LDL, HDL). In controls, it decreased in CM/RM by 10 h but remained in endogenous lipoproteins for 72 h, whereas in Type III hyperlipoproteinemia it was mainly in CM/RM. In vitro experiments showed rapid transfer of alpha-epoxy cholesterol from CM/RM to LDL and HDL, and LDL containing alpha-epoxy cholesterol showed increased susceptibility to copper oxidation.
Staprans I, Pan XM, Rapp JH, et al. J Lipid Res, 2003. PMID 12562864
2003 / Randomized controlled factorial trial
A randomized factorial trial evaluated dietary advice in 3,114 men under 70 years old with angina followed for 3 to 9 years. Neither oily fish advice nor fruit, vegetable, and oat advice reduced all-cause mortality. However, men advised to eat oily fish had a higher risk of cardiac death (adjusted hazard ratio 1.26; 95% CI, 1.00 to 1.58; P=0.047) and sudden cardiac death (HR 1.54; 95% CI, 1.06 to 2.23), concentrated in those given fish oil capsules.
Burr ML, Ashfield-Watt PA, Dunstan FD, et al. Eur J Clin Nutr, 2003. PMID 12571649
2003 / Randomized crossover trial
Twelve overweight patients with type 2 diabetes consumed three test meals in random order: a control meal with 50 g carbohydrate, the control meal plus 100 g butter, or the control meal plus 80 g olive oil. No significant differences were seen in glucose, insulin, or fatty acid responses between the two fat-rich meals. However, plasma and chylomicron triacylglycerol responses were highest after the butter meal, HDL-cholesterol concentrations decreased significantly only after butter, and GLP-1 responses were highest after the olive oil meal.
Thomsen C, Storm H, Holst JJ, et al. Am J Clin Nutr, 2003. PMID 12600850
2003 / Interventional physiological study
Thirteen tetraplegic patients with complete spinal cord injury ingested 500 mL of water after a 30-minute resting period and were monitored for 60 minutes. Water drinking elicited a pressor response within 5 minutes, with finger blood pressure increasing from 123±8/65±4 mm Hg at baseline to a peak of 138±8/73±4 mm Hg after 35 to 40 minutes (P<0.05). Heart rate decreased from 64±2 to 60±2 bpm (P<0.001), total peripheral resistance increased by 15±4% (P<0.05), and baroreflex sensitivity rose from 18±5 to 23±6 ms/mm Hg at 35 minutes (P<0.01).
Tank J, Schroeder C, Stoffels M, et al. Hypertension, 2003. PMID 12719442
2003 / Double-blind randomized crossover trial
Sixteen hypercholesterolemic men consumed milk containing 1.8 g/day of non-esterified pure plant sterols or control milk during two 6-day periods in a double-blind crossover design. Cholesterol absorption was measured using oral [2H]cholesterol and intravenous [13C]cholesterol stable isotope tracers. Cholesterol absorption was significantly reduced from 70.1 +/- 4.2% with control milk to 41.1 +/- 4.0% with plant sterol-enriched milk (P < 0.001).
Pouteau EB, Monnard IE, Piguet-Welsch C, et al. Eur J Nutr, 2003. PMID 12811473
2003 / Randomized controlled trial
Forty-six hyperlipidemic adults were randomized to 1 of 3 one-month outpatient interventions: a diet very low in saturated fat (control, n=16), the same diet plus 20 mg/d lovastatin (n=14), or a dietary portfolio high in plant sterols, soy protein, viscous fibers, and almonds (n=16). Mean (SE) decreases in LDL cholesterol were 8.0% (2.1%) for control, 30.9% (3.6%) for statin, and 28.6% (3.2%) for dietary portfolio. Respective reductions in C-reactive protein were 10.0% (8.6%), 33.3% (8.3%), and 28.2% (10.8%). The statin and portfolio groups differed significantly from control, with no significant differences in efficacy between the statin and dietary portfolio treatments.
Jenkins DJ, Kendall CW, Marchie A, et al. JAMA, 2003. PMID 12876093
2003 / Randomized controlled trial protocol
The Look AHEAD randomized controlled trial protocol was designed to assess the long-term effects (up to 11.5 years) of an intensive weight loss program delivered over 4 years in overweight and obese individuals with type 2 diabetes. Approximately 5,000 participants aged 45-74 years with BMI >=25 kg/m2 are randomized to an intensive lifestyle intervention (decreased caloric intake and increased physical activity) or a diabetes support and education control. The primary outcome is time to incidence of a major CVD event, powered to detect an 18% difference between groups.
Ryan DH, Espeland MA, Foster GD, et al. Control Clin Trials, 2003. PMID 14500058
2003 / Double-blind, randomized crossover trial
Twelve healthy older adults (aged 73.8 +/- 2.7 years) received oral L-arginine (8 g twice daily) or placebo for 14 days each in a randomized crossover trial separated by a 14-day washout. L-Arginine significantly improved brachial flow-mediated dilation to 5.7 +/- 1.2% (p < 0.0001), whereas placebo showed no significant effect (-0.25 +/- 0.7%). Plasma L-arginine levels increased from 57.4 +/- 5.0 to 114.9 +/- 11.6 micromol/l after L-arginine supplementation. ADMA levels were elevated at baseline compared to middle-aged individuals (3.9 +/- 0.2 vs. 1.0 +/- 0.1 micromol/l; p < 0.0001) and remained unchanged, but L-arginine normalized the L-arginine/ADMA ratio (p < 0.05).
Bode-Böger SM, Muke J, Surdacki A, et al. Vasc Med, 2003. PMID 14518608
2003 / Randomized controlled trial
In a controlled trial, 25 hyperlipidemic subjects consumed either a portfolio diet high in plant sterols, soy protein, viscous fibers, and almonds (n=13) or a low-saturated fat diet (n=12). Over 4 weeks, LDL-C decreased by 35.0% +/- 3.1% on the portfolio diet versus 12.1% +/- 2.4% on the control diet (P < .001). The LDL-C to HDL-C ratio was reduced by 30.0% +/- 3.5% on the portfolio diet, which was significantly greater than on the control diet (P < .001). Mean weight loss was similar (1.0 kg vs 0.9 kg), and no differences were found between diets for blood pressure, HDL-C, triglycerides, lipoprotein(a), or homocysteine.
Jenkins DJ, Kendall CW, Marchie A, et al. Metabolism, 2003. PMID 14624410
2003 / Controlled prospective trial
In 27 healthy participants, pulse wave amplitude was measured before and after 5 days of consuming flavanol-rich cocoa (821 mg flavanols/day), using time and flavanol-poor beverage controls, along with intravenous L-NAME infusion. Four days of flavanol-rich cocoa induced peripheral vasodilation (P = 0.009), with a large additional acute response on day 5 (P = 0.01). L-NAME completely reversed this vasodilation (P = 0.004). Flavanol-poor cocoa induced much smaller responses (P = 0.005), and no response occurred in the time-control study.
Fisher ND, Hughes M, Gerhard-Herman M, et al. J Hypertens, 2003. PMID 14654748
2002 / Controlled interventional study
Investigators evaluated vascular changes in 15 healthy young men after a high-fat meal, with five also receiving a low-fat control meal. Five hours postprandially, coronary flow reserve declined by 18% (95% CI, 13% to 23%) in the full cohort, while triglycerides rose from 1.1 to 2.8 mmol/L (P < 0.001). Among participants receiving both meals, coronary flow reserve fell after the lipid load but rose following the low-fat meal (P = 0.03).
Hozumi T, Eisenberg M, Sugioka K, et al. Ann Intern Med, 2002. PMID 11926787
2002 / Randomized controlled trial
In a 3-month double-blind randomized trial of 40 men and women with mild-to-moderate hypertension, drinking 500 mL of soy milk twice daily significantly decreased blood pressure compared to cow's milk. Systolic blood pressure fell by 18.4 +/- 10.7 mmHg versus 1.4 +/- 7.2 mmHg with cow's milk (P < 0.0001), and diastolic fell by 15.9 +/- 9.8 mmHg versus 3.7 +/- 5.0 mmHg (P < 0.0001). Blood pressure reductions correlated strongly with urinary genistein excretion.
Rivas M, Garay RP, Escanero JF, et al. J Nutr, 2002. PMID 12097666
2002 / Randomized placebo-controlled trial
A total of 20,536 high-risk UK adults were randomly allocated to receive daily antioxidant vitamins (600 mg vitamin E, 250 mg vitamin C, and 20 mg beta-carotene) or placebo for 5 years. There were no significant differences in all-cause mortality (14.1% vitamin vs 13.5% placebo), vascular deaths (8.6% vs 8.2%), or non-vascular deaths (5.5% vs 5.3%). Major vascular events occurred in 22.5% of participants in both the vitamin and placebo groups (event rate ratio 1.00, 95% CI 0.94-1.06). There were also no significant effects observed on cancer incidence or hospitalisation for other non-vascular causes.
Heart Protection Study Collaborative Group Lancet, 2002. PMID 12114037
2002 / Randomized controlled trial
A randomized trial assigned 36 overweight men aged 50 to 75 years to consume daily oat or wheat cereal providing 14 g of fiber for 12 weeks. Significant time-by-treatment interactions favored oats for LDL cholesterol (-2.5% vs 8.0%), small LDL cholesterol (-17.3% vs 60.4%), and LDL particle number (-5.0% vs 14.2%). Neither HDL cholesterol subclasses nor insulin sensitivity changed significantly.
Davy BM, Davy KP, Ho RC, et al. Am J Clin Nutr, 2002. PMID 12145006
2002 / Randomized crossover trial
In a randomized crossover trial, 10 healthy young adults and 4 cardiac transplant recipients consumed 500 ml or 20 ml of tap water. In healthy participants, drinking 500 ml reduced heart rate from 67.6±2.0 to 60.7±2.4 beats per minute (P<0.01) without altering arterial blood pressure. Water ingestion simultaneously increased high frequency heart rate variability, with RMSSD rising by 13±2.7 ms compared to 2±3.1 ms after 20 ml (P<0.05).
Routledge HC, Chowdhary S, Coote JH, et al. Clin Sci (Lond), 2002. PMID 12149107
2002 / Randomized crossover trial
In a randomized crossover trial, 27 hyperlipidemic adults consumed isoenergetic snack supplements of full-dose almonds (73+/-3 g/day), half-dose almonds plus muffins, or full-dose muffins for one month each. Full- and half-dose almonds reduced LDL cholesterol (9.4+/-1.9%, P<0.001 and 4.4+/-1.7%, P=0.018) and LDL:HDL ratio (12.0+/-2.1%, P<0.001 and 7.8+/-2.2%, P=0.001). Full-dose almonds also lowered oxidized LDL by 14.0+/-3.8% and lipoprotein(a) by 7.8+/-3.5%, without affecting pulmonary nitric oxide.
Jenkins DJ, Kendall CW, Marchie A, et al. Circulation, 2002. PMID 12221048
2002 / Randomized controlled trial
Ninety ambulatory patients aged 28 to 66 were randomly assigned to dietitian-led medical nutrition therapy or physician usual care. The nutrition therapy group experienced no change in food enjoyment compared to usual care, but reported improvements in quality of life regarding convenience, cost, and lasting gains in self-care. Patients receiving nutrition therapy also showed higher satisfaction with cholesterol management, eating habits, and overall life without reporting lifestyle restrictions.
Delahanty LM, Hayden D, Ammerman A, et al. Ann Behav Med, 2002. PMID 12434938
2002 / Randomized controlled crossover trial
In a randomized crossover trial, 13 healthy adults consumed either 500 mL or 50 mL of water a quarter hour prior to head-up tilt testing. Ingesting 500 mL lengthened orthostatic tolerance by 5 ± 1 minutes (range -1 to +11 minutes, P < 0.001) and modestly raised supine mean arterial pressure (P < 0.01). The larger volume also blunted tilt-induced heart rate acceleration and improved cerebral blood flow regulation.
Schroeder C, Bush VE, Norcliffe LJ, et al. Circulation, 2002. PMID 12451007
2002 / Randomized controlled trial
Twenty-eight men with type 2 diabetes and serum ferritin >200 ng/ml were randomized to iron depletion (three 500-ml blood extractions at 2-week intervals) or observation, with vascular reactivity evaluated at baseline, 4 months, and 12 months. Endothelium-dependent vasodilation remained essentially unchanged in both groups. In contrast, vasodilation induced by glyceryl trinitrate (GTN) improved significantly after iron depletion (P = 0.006) alongside decreases in transferrin saturation index and HbA1c (-0.6%, P < 0.05). Changes in endothelium-independent vasodilation correlated with the change in serum ferritin (r = -0.45, P = 0.04), and change in HbA1c was the best predictor of these modifications. At 12 months, transferrin saturation index and GTN-induced vasodilation returned to values similar to baseline.
Fernández-Real JM, Peñarroja G, Castro A, et al. Diabetes Care, 2002. PMID 12453969
2002 / Uncontrolled clinical intervention study
Sixty-eight consecutive patients with borderline hypertension underwent an inpatient program consisting of a 1-2 day fruit and vegetable prefast, an average of 13.6 days of medically supervised water-only fasting, and an average of 6.0 days of refeeding with a low-fat, low-sodium, plant-based vegan diet. By the end of treatment, approximately 82% of subjects achieved blood pressure at or below 120/80 mm Hg. The mean blood pressure reduction was 20/7 mm Hg, with the largest reductions seen in subjects with the highest baseline blood pressure.
Goldhamer AC, Lisle DJ, Sultana P, et al. J Altern Complement Med, 2002. PMID 12470446
2002 / Comparative physiological intervention study
Researchers evaluated coronary blood flow in the distal LAD before and up to 60 minutes after food intake in 20 healthy controls and 20 patients with significant coronary stenosis. In healthy controls, Dtvi and Dtvi x HR peaked at 15 minutes postprandially (Dtvi x HR: 862.2 +/- 261.5 vs. 1,174.2 +/- 307.5 cm/min, p = 0.002). In contrast, patient values decreased, reaching a nadir at 45 minutes (Dtvi x HR: 1,449.6 +/- 1,044.0 vs. 1,273.4 +/- 1,000.9 cm/min, p = 0.002). In six patients tested after successful coronary intervention, the normal postprandial blood flow surge was restored.
Chung WY, Sohn DW, Kim YJ, et al. J Am Coll Cardiol, 2002. PMID 12475458
2002 / Intervention study
Hyperlipidemic subjects consuming a background low-saturated fat diet were placed on a 1-month combination diet high in plant sterols (1 g/1,000 kcal), soy protein (23 g/1,000 kcal), and viscous fibers (9 g/1,000 kcal). The combination diet was rated as acceptable and very filling, reducing LDL cholesterol by 29.0% +/- 2.7% (P < .001) and the LDL-to-HDL ratio by 26.5% +/- 3.4% (P < .001), with near maximal reductions by week 2. In one participant tested on control and lovastatin diets, LDL:HDL reductions on lovastatin were similar to the combination diet.
Jenkins DJ, Kendall CW, Faulkner D, et al. Metabolism, 2002. PMID 12489074
2002 / Pilot, randomized, double-blind study
In a pilot, double-blind study, 36 patients with dyslipidemia and type 2 diabetes on a cholesterol-lowering diet were randomized to receive policosanol (10 mg/day) or lovastatin (20 mg/day) for 8 weeks. Policosanol significantly lowered LDL-C by 29.9%, total cholesterol by 21.1%, triglycerides by 13.6%, and increased HDL-C by 12.5%, outperforming lovastatin in raising HDL-C and reducing lipid ratios (p < 0.05). Policosanol also improved lag time of LDL peroxidation by 20.9% and plasma antioxidant activity by 24.2%. Both treatments reduced lipid peroxidation markers and were well tolerated, though the authors note further studies with larger sample sizes are required.
Castaño G, Menéndez R, Más R, et al. Int J Clin Pharmacol Res, 2002. PMID 12837046
2001 / Randomized crossover trial within a parallel-group diet assignment
A total of 412 participants were randomized to a control diet or the DASH diet and consumed high, intermediate, and low sodium levels for 30 consecutive days each in random order. Reducing sodium from high to intermediate decreased systolic blood pressure by 2.1 mm Hg on the control diet (P<0.001) and 1.3 mm Hg on the DASH diet (P=0.03); reducing from intermediate to low caused further drops of 4.6 mm Hg (P<0.001) and 1.7 mm Hg (P<0.01), respectively. Compared with the high-sodium control diet, the low-sodium DASH diet lowered systolic blood pressure by 7.1 mm Hg in participants without hypertension and by 11.5 mm Hg in those with hypertension.
Sacks FM, Svetkey LP, Vollmer WM, et al. N Engl J Med, 2001. PMID 11136953